1.
Mashayekhi P, Noruzinia M, Khodaverdi S. Metformin as a potential agent for modulating the faulty endometriotic mesenchymal stem cells: A case-control study. IJRM [Internet]. 2022Nov.2 [cited 2024Mar.29];20(10):861–872. Available from: https://knepublishing.com/index.php/ijrm/article/view/12270